Log In
Print this Print this

deferasirox (Jadenu)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionOnce-daily tablet formulation of Exjade deferasirox, an iron chelating agent
Molecular Target
Mechanism of ActionChelating agent
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today